Medtronic has launched an exchange offer allowing its shareholders to swap their Medtronic shares for MiniMed Group shares at a 7% discount, expected to be tax-free for U.S. federal income tax purposes. MiniMed, formerly Medtronic's Diabetes business, went public in March 2026 with Medtronic retaining about 90% ownership. This move aims to spin off at least 80.1% of MiniMed shares, enabling MiniMed to operate independently and allowing Medtronic to focus on its Cardiovascular, Neuroscience, and Surgical divisions. The offer is voluntary, with conditions including a minimum number of shares tendered and legal tax opinions, and is expected to conclude around October 9, 2026.
Medtronic is offering to exchange up to 225 million shares of MiniMed common stock it owns for Medtronic ordinary shares, aiming to complete its separation from MiniMed. Currently holding about 89.86% of MiniMed, Medtronic intends to exchange all its...
Medtronic and Abbott are both strong dividend-paying medical device companies, but Medtronic currently offers a higher dividend yield of 3.11% and stronger near-term growth prospects, including accelerating revenue and a planned diabetes business sep...
